Delivery Order SPE2DB20D1100-SPE2DB25FA4R9

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $1,097.34 and a period of performance ending on July 22, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order (SPE2DB20D3304|SPE2DB24FW6W6) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565334515 - LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $3,392.02 and a completion date of August 5, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The delivery order, valued at $2,561.14, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This IDC enables the DLA to efficiently procure a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565616944 ! LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $10,010.10 and is a firm fixed price delivery order with an ultimate completion date of August 29, 2024. It is not a set-aside contract. This order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $2,457.21 and a completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566807824 - LIDOCAINE 5% PATCH 30S, a medical product, with a ceiling value of $2,363.52 and a period of performance through December 31, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S medical products, with a ceiling value of $3,255.33 and a period of performance through February 3, 2025. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. military....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566708440 - LIDOCAINE 5% PATCH 30S, a medical product used for pain management. The contract has a ceiling value of $21,435.54 and a period of performance ending on December 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $7,678.86 and is a Firm Fixed Price (FFP) contract type. It does not have a set-aside designation. The ultimate completion date for this delivery order is September 23, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order for the supply of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,401.92 and an ultimate completion date of December 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA4R9
    Delivery Order

This is a delivery order (SPE2DB20D1100|SPE2DB25FA4R9) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LIDOCAINE 5% PATCH 30S. The contract has a ceiling value of $9,716.34 and a completion date of February 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/7/25, 10:00 AM